California Public Employees Retirement System’s Matinas BioPharma MTNB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-7,054
Closed -$370K 2398
2021
Q1
$370K Hold
7,054
﹤0.01% 3125
2020
Q4
$480K Hold
7,054
﹤0.01% 2938
2020
Q3
$270K Hold
7,054
﹤0.01% 3134
2020
Q2
$273K Buy
7,054
+5,394
+325% +$207K ﹤0.01% 3064
2020
Q1
$50K Hold
1,660
﹤0.01% 3255
2019
Q4
$188K Buy
+1,660
New +$96.2K ﹤0.01% 3128

Other funds holding MTNB

California Public Employees Retirement System's MTNB Position: Q2 2021 in Review

California Public Employees Retirement System sold out of Matinas BioPharma (MTNB) in Q2 2021, closing a stake of 7,054 shares — an estimated $370K sold.

California Public Employees Retirement System first reported a position in MTNB in Q4 2019 and held it in 6 quarters. The position peaked at $480K in Q4 2020. 67 funds tracked by Wall St. Rank hold MTNB as of Q2 2021.

  • California Public Employees Retirement System reported no remaining Matinas BioPharma position as of Q2 2021 after selling out during the quarter.
  • California Public Employees Retirement System sold 7,054 Matinas BioPharma shares in Q2 2021, an estimated $370K.
  • California Public Employees Retirement System first reported a position in Matinas BioPharma in Q4 2019 and held it in 6 quarters.
  • California Public Employees Retirement System's Matinas BioPharma position peaked at $480K in Q4 2020.
  • 67 funds tracked by Wall St. Rank held Matinas BioPharma as of Q2 2021.

Based on California Public Employees Retirement System's 13F filing for Q2 2021, filed 13 Aug 2021.